98 related articles for article (PubMed ID: 26796506)
21. BRAF V600E mutational status in pediatric thyroid cancer.
Henke LE; Perkins SM; Pfeifer JD; Ma C; Chen Y; DeWees T; Grigsby PW
Pediatr Blood Cancer; 2014 Jul; 61(7):1168-72. PubMed ID: 24677749
[TBL] [Abstract][Full Text] [Related]
22. Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.
Go H; Jeon YK; Huh J; Choi SJ; Choi YD; Cha HJ; Kim HJ; Park G; Min S; Kim JE
Histopathology; 2014 Aug; 65(2):261-72. PubMed ID: 24720374
[TBL] [Abstract][Full Text] [Related]
23. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.
Ballester LY; Sarabia SF; Sayeed H; Patel N; Baalwa J; Athanassaki I; Hernandez JA; Fang E; Quintanilla NM; Roy A; López-Terrada DH
Pediatr Dev Pathol; 2016; 19(2):94-100. PubMed ID: 26366474
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical staining for BRAF V600E supports the diagnosis of metanephric adenoma.
Pinto A; Signoretti S; Hirsch MS; Barletta JA
Histopathology; 2015 May; 66(6):901-4. PubMed ID: 25130952
[No Abstract] [Full Text] [Related]
25. Evidence for BRAF V600E and H3F3A K27M double mutations in paediatric glial and glioneuronal tumours.
Nguyen AT; Colin C; Nanni-Metellus I; Padovani L; Maurage CA; Varlet P; Miquel C; Uro-Coste E; Godfraind C; Lechapt-Zalcman E; Labrousse F; Gauchotte G; Silva K; Jouvet A; Figarella-Branger D;
Neuropathol Appl Neurobiol; 2015 Apr; 41(3):403-8. PubMed ID: 25389051
[No Abstract] [Full Text] [Related]
26. Utility of BRAF V600E mutation-specific immunohistochemistry in detecting BRAF V600E-mutated gastrointestinal stromal tumors.
Patil DT; Ma S; Konishi M; Carver PD; Pukay M; Beadling C; Corless CL; Rubin BP
Am J Clin Pathol; 2015 Nov; 144(5):782-9. PubMed ID: 26486743
[TBL] [Abstract][Full Text] [Related]
27. BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas.
Lee D; Cho YH; Kang SY; Yoon N; Sung CO; Suh YL
J Surg Oncol; 2015 Mar; 111(3):359-64. PubMed ID: 25346165
[TBL] [Abstract][Full Text] [Related]
28. Activating BRAF V600E mutation in aggressive pediatric Langerhans cell histiocytosis: demonstration by allele-specific PCR/direct sequencing and immunohistochemistry.
Méhes G; Irsai G; Bedekovics J; Beke L; Fazakas F; Rózsa T; Kiss C
Am J Surg Pathol; 2014 Dec; 38(12):1644-8. PubMed ID: 25118810
[TBL] [Abstract][Full Text] [Related]
29. BRAF mutations are also associated with neurocutaneous melanocytosis and large/giant congenital melanocytic nevi.
Salgado CM; Basu D; Nikiforova M; Bauer BS; Johnson D; Rundell V; Grunwaldt LJ; Reyes-Múgica M
Pediatr Dev Pathol; 2015; 18(1):1-9. PubMed ID: 25490715
[TBL] [Abstract][Full Text] [Related]
30. Molecular characterization of a selected cohort of patients affected by pulmonary metastases of malignant melanoma: Hints from BRAF, NRAS and EGFR evaluation.
Ulivieri A; Cardillo G; Manente L; Paone G; Mancuso AP; Vigna L; Di Stasio E; Gasbarra R; Girlando S; Leone A
Oncotarget; 2015 Aug; 6(23):19868-79. PubMed ID: 26305188
[TBL] [Abstract][Full Text] [Related]
31. Real-world experience of
Langabeer SE; O'Brien D; McCarron S; Bacon CL; Vandenberghe E
J Clin Pathol; 2021 Dec; 74(12):819. PubMed ID: 33372104
[No Abstract] [Full Text] [Related]
32. Novel clinicopathological and molecular characterization of metanephric adenoma: a study of 28 cases.
Ding Y; Wang C; Li X; Jiang Y; Mei P; Huang W; Song G; Wang J; Ping G; Hu R; Miao C; He X; Chen G; Li H; Zhu Y; Zhang Z
Diagn Pathol; 2018 Aug; 13(1):54. PubMed ID: 30111351
[TBL] [Abstract][Full Text] [Related]
33. NRAS (Q61R), BRAF (V600E) immunohistochemistry: a concomitant tool for mutation screening in melanomas.
Uguen A; Talagas M; Costa S; Samaison L; Paule L; Alavi Z; De Braekeleer M; Le Marechal C; Marcorelles P
Diagn Pathol; 2015 Jul; 10():121. PubMed ID: 26204954
[TBL] [Abstract][Full Text] [Related]
34. Mutually exclusive BCOR internal tandem duplications and YWHAE-NUTM2 fusions in clear cell sarcoma of kidney: not the full story.
Kenny C; Bausenwein S; Lazaro A; Furtwängler R; Gooskens SL; van den Heuvel Eibrink M; Vokuhl C; Leuschner I; Graf N; Gessler M; O'Sullivan MJ
J Pathol; 2016 Apr; 238(5):617-20. PubMed ID: 27000436
[TBL] [Abstract][Full Text] [Related]
35. Investigation of BRAF V600E mutation in papillary thyroid carcinoma and tumor-surrounding nontumoral tissues.
Dağlar-Aday A; Toptaş B; Oztürk T; Seyhan F; Saygili N; Eronat AP; Akadam-Teker B; Yilmaz-Aydoğan H; Aksoy F; Oztürk O
DNA Cell Biol; 2013 Jan; 32(1):13-8. PubMed ID: 23157614
[TBL] [Abstract][Full Text] [Related]
36. Somatic BRAF-V600E mutations in familial colorectal cancer.
Vandrovcova J; Lagerstedt-Robinsson K; Påhlman L; Lindblom A
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2270-3. PubMed ID: 17119056
[TBL] [Abstract][Full Text] [Related]
37. BRAF V600E mutational status in bile duct adenomas and hamartomas.
Pujals A; Bioulac-Sage P; Castain C; Charpy C; Zafrani ES; Calderaro J
Histopathology; 2015 Oct; 67(4):562-7. PubMed ID: 25704541
[TBL] [Abstract][Full Text] [Related]
38. BRAF(K601E) mutation in a patient with a follicular thyroid carcinoma.
Pennelli G; Vianello F; Barollo S; Pezzani R; Merante Boschin I; Pelizzo MR; Mantero F; Rugge M; Mian C
Thyroid; 2011 Dec; 21(12):1393-6. PubMed ID: 22136270
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases.
Capper D; Berghoff AS; Magerle M; Ilhan A; Wöhrer A; Hackl M; Pichler J; Pusch S; Meyer J; Habel A; Petzelbauer P; Birner P; von Deimling A; Preusser M
Acta Neuropathol; 2012 Feb; 123(2):223-33. PubMed ID: 22012135
[TBL] [Abstract][Full Text] [Related]
40. Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma.
Eisenhardt AE; Olbrich H; Röring M; Janzarik W; Anh TN; Cin H; Remke M; Witt H; Korshunov A; Pfister SM; Omran H; Brummer T
Int J Cancer; 2011 Nov; 129(9):2297-303. PubMed ID: 21190184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]